Sheelakumari Raghavan

Dr. Sheelakumari Raghavan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in Neurobiology of Aging
Verified
Journal Article
Closed access
SRSheelakumari Raghavan
Sheelakumari Raghavan
SPScott A. Przybelski
Scott A. Przybelski
RRRobert I. Reid
Robert I. Reid
JGJonathan Graff-Radford
Jonathan Graff-Radford
TLTimothy G. Lesnick
Timothy G. Lesnick
PVPrashanthi Vemuri
Prashanthi Vemuri

5 February 2022 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
SRSheelakumari Raghavan
Sheelakumari Raghavan
SPScott A. Przybelski
Scott A. Przybelski
RRRobert I. Reid
Robert I. Reid
TLTimothy G. Lesnick
Timothy G. Lesnick
VRVijay K. Ramanan
Vijay K. Ramanan
PVPrashanthi Vemuri
Prashanthi Vemuri
Multi-compartment modelling of white matter microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) can provide information on white matter health through neurite density index and free water measures. We hypothesized that cerebrovascular disease, Alzheimer’s disease, and TDP-43 proteinopathy would be associated with distinct NODDI readouts of white matter damage which would be informative for identifying the substrate for cognitive impairment. We identified two independent cohorts with multi-shell diffusion MRI, amyloid and tau PET, and cognitive assessments: specifically, a population-based cohort of 347 elderly randomly sampled from the Olmsted county, Minnesota, population and a clinical research-based cohort of 61 amyloid positive Alzheimer’s dementia participants. We observed an increase in free water and decrease in neurite density using NODDI measures in the genu of the corpus callosum associated with vascular risk factors, which we refer to as the vascular white matter component. Tau PET signal reflective of 3R/4R tau deposition was associated with worsening neurite density index in the temporal white matter where we measured parahippocampal cingulum and inferior temporal white matter bundles. Worsening temporal white matter neurite density was associated with (antemortem confirmed) FDG TDP-43 signature. Post-mortem neuropathologic data on a small subset of this sample lend support to our findings. In the community-dwelling cohort where vascular disease was more prevalent, the NODDI vascular white matter component explained variability in global cognition (partial R2of free water and neurite density = 8.3%) and MMSE performance (8.2%) which was comparable to amyloid PET (7.4% for global cognition and 6.6% for memory). In the AD dementia cohort, tau deposition was the greatest contributor to cognitive performance (9.6%), but there was also a non-trivial contribution of the temporal white matter component (8.5%) to cognitive performance. The differences observed between the two cohorts were reflective of their distinct clinical composition. White matter microstructural damage assessed using advanced diffusion models may add significant value for distinguishing the underlying substrate (whether cerebrovascular disease versus neurodegenerative disease caused by tau deposition or TDP-43 pathology) for cognitive impairment in older adults.Graphical abstract

30 May 2023 in Neurology
Verified
Journal Article
Open access
PDF file
JTJianqiao Tian
Jianqiao Tian
SRSheelakumari Raghavan
Sheelakumari Raghavan
RRRobert I. Reid
Robert I. Reid
SPScott A. Przybelski
Scott A. Przybelski
TLTimothy G. Lesnick
Timothy G. Lesnick
PVPrashanthi Vemuri
Prashanthi Vemuri
Background and Objective: The dynamics of white matter (WM) changes are understudied in Alzheimer’s disease (AD). Our goal was to study the association between flortaucipir PET and WM health using NODDI and evaluate its association with cognitive performance. Specifically, we focused on NODDI’s Neurite Density Index (NDI), which aids in capturing axonal degeneration in WM and has greater specificity than single-shell diffusion MRI methods Method: We estimated regional flortaucipir PET SUVRs from three regions corresponding to Braak stage I, III/IV, and V/VI to capture the spatial distribution pattern of the 3R/4R tau in AD. Then, we evaluated the associations between these measurements and NDIs in 29 candidate WM tracts using Pearson correlation and multiple regression models Results: Based on 223 participants who were amyloid positive (mean age of 78 y/o and 57.0% male, 119 cognitively unimpaired, 56 MCI, 48 dementia), the results showed that WM tracts NDI decreased with increasing regional Braak tau SUVRs. Of all the significant WM tracts, the uncinate fasciculus (r=-0.274 for Braak I, -0.311 for Braak III/IV, and -0.292 for Braak V/VI, p< 0.05) and cingulum adjoining hippocampus (r= -0.274, -0.288, -0.233, p< 0.05), both tracts anatomically connected to areas of early tau deposition, were consistently found to be within the top five distinguishing WM tracts associated with flortaucipir SUVRs. The increase in tau deposition measurable outside the medial temporal lobes in Braak III-VI was associated with a decrease in NDI in the middle and inferior temporal WM tracts. For cognitive performance, WM NDI had similar coefficients of determination (r2=31%) as regional Braak flortaucipir SUVRs (29%), and together WM NDI and regional Braak flortaucipir SUVRs explained 46% of the variance in cognitive performance Discussion: We found spatially dependent WM degeneration associated with regional flortaucipir SUVRs in Braak stages, suggesting a spatial pattern in WM damage. NDI, a specific marker of axonal density, provides complementary information about disease staging and progression in addition to tau deposition. Measurements of WM changes are important for the mechanistic understanding of multifactorial pathways through which AD causes cognitive dysfunction.

6 November 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SRSheelakumari Raghavan
Sheelakumari Raghavan
SPScott A. Przybelski
Scott A. Przybelski
TLTimothy G. Lesnick
Timothy G. Lesnick
AFAngela J. Fought
Angela J. Fought
RRRobert I. Reid
Robert I. Reid
PVPrashanthi Vemuri
Prashanthi Vemuri
INTRODUCTION: Cost‐effective screening tools for vascular contributions to cognitive impairment and dementia (VCID) has significant implications. We evaluated non‐imaging indicators of VCID using magnetic resonance imaging (MRI)‐measured white matter (WM) damage and hypothesized that these indicators differ based on age.METHODS: In 745 participants from the Mayo Clinic Study of Aging (≥50 years of age) with serial WM assessments from diffusion MRI and fluid‐attenuated inversion recovery (FLAIR)‐MRI, we examined associations between baseline non‐imaging indicators (demographics, vascular risk factors [VRFs], gait, behavioral, plasma glial fibrillary acidic protein [GFAP], and plasma neurofilament light chain [NfL]) and WM damage across three age tertiles.RESULTS: VRFs and gait were associated with diffusion changes even in low age strata. All measures (VRFs, gait, behavioral, plasma GFAP, plasma NfL) were associated with white matter hyperintensities (WMHs) but mainly in intermediate and high age strata.DISCUSSION: Non‐imaging indicators of VCID were related to WM damage and may aid in screening participants and assessing outcomes for VCID.Highlights: Non‐imaging indicators of VCID can aid in prediction of MRI‐measured WM damage but their importance differed by age. Vascular risk and gait measures were associated with early VCID changes measured using diffusion MRI. Plasma markers explained variability in WMH across age strata. Most non‐imaging measures explained variability in WMH and vascular WM scores in intermediate and older age groups. The framework developed here can be used to evaluate new non‐imaging VCID indicators proposed in the future.

2 July 2024 in European Journal of Radiology
Verified
Journal Article
Closed access
JPJoseph Suresh Paul
Joseph Suresh Paul
ATArun Raj T
Arun Raj T
SRSheelakumari Raghavan
Sheelakumari Raghavan
CKChandrasekharan Kesavadas
Chandrasekharan Kesavadas

19 December 2025 in Cerebral Circulation - Cognition and Behavior
Verified
Journal Article
Open access
SRSheelakumari Raghavan
Sheelakumari Raghavan
SPScott A. Przybelski
Scott A. Przybelski
RRRobert I. Reid
Robert I. Reid
MKMichael G. Kamykowski
Michael G. Kamykowski
JGJonathan Graff-Radford
Jonathan Graff-Radford
PVPrashanthi Vemuri
Prashanthi Vemuri
Diffusion MRI (dMRI) has been proposed for quantifying early tissue changes in cerebral small vessel disease (SVD). We evaluated the regional dependance of predictors of white matter (WM) damage and compared the utility of longitudinal WM changes in the commonly available diffusion MRI measures for vascular contribution to cognitive impairment and dementia (VCID) prevention trials. We included 718 participants (mean age: 71.1(9.6) years, 56 % males) with at least two dMRI scans, amyloid-PET, and structural imaging. We computed single-shell dMRI measures (fractional anisotropy, mean diffusivity, free water, peak-width skeletonized mean diffusivity (PSMD) and assessed: i) regional dependance of predictors of baseline WM damage using voxel-level analyses; ii) longitudinal associations between dMRI measures and cognition; and iii) sample size estimates for a hypothetical clinical trial considering the regional and global dMRI measures as markers for VCID. We also included white matter hyperintensities (WMH) and our recently proposed composite vascular WM score (combination of WMH and fractional anisotropy of the genu) as a comparison. Vascular risk was consistently associated with dMRI changes in the genu of the corpus callosum. All SVD markers correlated with cognitive performance longitudinally. Global free water and the composite score provided the smallest sample size estimates, especially in participants with prevalent vascular disease (aged 70–89). dMRI markers had significant frontal lobe changes due to vascular risk and were sensitive to cognitive decline. The composite vascular WM score, global free water, and WMH emerged as promising VCID biomarkers, but further validation is needed in multiple populations.